Spetzler David Baxley (CIK 2071953) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-04). Recent activity: Buy CAI (1.0M shares), Sell CAI (393,100 shares), Sell CAI (84,900 shares), Buy CAI (250,000 shares), Sell CAI (119,212 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Caris Life Sciences, Inc. (CAI) | President | Buy | 1.0M | $2.4M |
| 2026-09-04 | Caris Life Sciences, Inc. (CAI) | President | Sell | 393,100 | $9.7M |
| 2026-09-04 | Caris Life Sciences, Inc. (CAI) | President | Sell | 84,900 | $2.1M |
| 2026-09-04 | Caris Life Sciences, Inc. (CAI) | President | Buy | 250,000 | $610,000 |
| 2026-09-04 | Caris Life Sciences, Inc. (CAI) | President | Sell | 119,212 | $3.0M |
| 2026-05-18 | Caris Life Sciences, Inc. (CAI) | President | Sell | 13,856 | $211,304 |
| 2026-03-10 | Caris Life Sciences, Inc. (CAI) | President | Buy | 83,162 | $0 |
| 2025-11-10 | Caris Life Sciences, Inc. (CAI) | President | Buy | 400 | $9,540 |
| 2025-08-13 | Caris Life Sciences, Inc. (CAI) | President | Sell | 63,509 | $1.9M |
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | President | Sell | 700,509 | $13.0M |
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | President | Buy | 132,428 | $0 |
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | President | Buy | 75,000 | $183,000 |
| 2025-06-23 | Caris Life Sciences, Inc. (CAI) | President | Sell | 34,782 | $947,810 |
来源：SEC Form 4 申报文件 · 截至 2026-09-04